65219-828 : Otulfi 130 mg/26ml Intravenous Solution
NDC: | 65219-828 |
Labeler: | Fresenius Kabi USA, LLC |
Product Type: | Human Prescription Drug |
Drug Name: | ![]() |
Dosage Form: | Intravenous Solution |
Application #: | BLA761379 |
Rev. Date: |
NDC Package Codes:
- 65219-828-05: 1 VIAL IN 1 CARTON (65219‑828‑05) / 26 ML IN 1 VIAL
Active Ingredients:
- Ustekinumab
Dosage Strength:
- 130 mg/26mL
Pharmaceutical Classes:
- Interleukin-12 Antagonist [EPC]
- Interleukin-12 Antagonists [MoA]
- Interleukin-23 Antagonist [EPC]
- Interleukin-23 Antagonists [MoA]
Related Products:
Based on records with the same trade name.- 65219-824 Otulfi 45 mg/.5ml Subcutaneous Injection, Solution by Fresenius Kabi USA, LLC
- 65219-826 Otulfi 90 mg/ml Subcutaneous Injection, Solution by Fresenius Kabi USA, LLC
NDC QR Code
Scan the QR code below to easily reference this data in the future:
< Prev: 65219-826Next: 65222-034 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.